Opioid Hedonic Hotspot in Nucleus Accumbens Shell: Mu, Delta, and Kappa Maps for Enhancement of Sweetness “Liking” and “Wanting” | Journal of Neuroscience
Kappa opioid receptor labeled with Tb (HTRF transiently expressing cells)
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Role of Kappa Opioid Receptors in Symptoms of Schizophrenia: What Is the Neurobiology? - Biological Psychiatry
The Role of Opioids and Their Receptors in Urological Malignancy: A Review | Journal of Urology
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Scientists Just Solved a Major Piece of the Opioid Puzzle | WIRED
Nephrology Jrnl Club on Twitter: "Difelikefalin (CR845) (KORSUVA) is a peripherally restricted, selective kappa opioid receptor agonist that exerts antipruritic effects by means of activation of kappa opioid receptors on peripheral neurons
κ-opioid receptor - Wikipedia
Structure of the human κ-opioid receptor in complex with JDTic | Nature
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
κ-opioid receptor - Wikipedia
How Kappa Opioid Receptors Drive Anxiety – PsychLiverpool
Kappa Receptors – Opioid Peptides
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
Opioids in cancer: The κ‑opioid receptor (Review)
Activation of opioid receptors in the enteric nervous system. MOR mu... | Download Scientific Diagram
